Wells Fargo’s Sotera Health SHC Stock Holding History

Wells Fargo’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$1.79K	–	7681
2023 Q1	$1.79K	Buy	+100	New	+$1.67K	﹤0.01%	6247

Other funds holding SHC

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

DCP

Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Wells Fargo's SHC Position: Q2 2026 in Review

Wells Fargo reduced its Sotera Health (SHC) stake by 99% in Q2 2026, selling an estimated $62.3M and leaving 52,050 shares worth $924K. The position accounts for ﹤0.01% of the portfolio, ranked #4164.

Wells Fargo first reported a position in SHC in Q4 2020 and has held it in 23 quarters since. The position peaked at $58.7M in Q1 2021. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

Wells Fargo held 52,050 shares of Sotera Health worth $924K as of Q2 2026.
Wells Fargo sold 3,954,229 Sotera Health shares in Q2 2026, an estimated $62.3M.
Sotera Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4164 holding.
Wells Fargo first reported a position in Sotera Health in Q4 2020 and has held it in 23 quarters since.
Wells Fargo's Sotera Health position peaked at $58.7M in Q1 2021.
320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.